Lee Biosolutions 125-10

Adrenomedullin (Human) - I-125 Labeled Purified IgG
T-G-010-01 10 μCi
EUR 1145.88

Human IgG antibody Laboratories manufactures the lee biosolutions 125-10 reagents distributed by Genprice. The Lee Biosolutions 125-10 reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact Lee Biosolutions Ltd.. Other Lee products are available in stock. Specificity: Lee Category: Biosolutions Group: 125-10

True Blue
5.0mg
EUR 595

True Blue
5(mg
EUR 635

True Blue
5x5(mg
EUR 2705

True Blue
10mg Ask for price
Description: True Blue

True Blue
1g Ask for price
Description: True Blue

True Blue
1mg Ask for price
Description: True Blue

True Blue
50mg Ask for price
Description: True Blue

125-10 information

8MTT
8MTT-50mg 50 mg Ask for price
Description: 8MTTis the first commercially available, full-length, genetically detoxified tetanus toxin. As a full-length protein, 8MTT contains all the tetanus toxin epitopes. 8MTT is more thermal and pH stable than CRM197. 8MTT is comparable to tetanus toxoid as a carrier protein. At 150 kDa, 8MTT is about 3 times the mass of CRM197and has ~35 surface accessible lysines vs ~10 for the latter, allowing for higher hapten loading.

8MTT
8MTT-5mg 5 mg Ask for price
Description: 8MTTis the first commercially available, full-length, genetically detoxified tetanus toxin. As a full-length protein, 8MTT contains all the tetanus toxin epitopes. 8MTT is more thermal and pH stable than CRM197. 8MTT is comparable to tetanus toxoid as a carrier protein. At 150 kDa, 8MTT is about 3 times the mass of CRM197and has ~35 surface accessible lysines vs ~10 for the latter, allowing for higher hapten loading.

8MTT-Bromoacetate
8MTT-Bromoacetate-10mg 10 mg Ask for price
Description: 8MTTis the first commercially available, full-length, genetically detoxified tetanus toxin. As a full-length protein, 8MTT contains all the tetanus toxin epitopes. 8MTT is more thermal and pH stable than CRM197. 8MTT is comparable to tetanus toxoid as a carrier protein. At 150 kDa, 8MTT is about 3 times the mass of CRM197and has ~35 surface accessible lysines vs ~10 for the latter, allowing for higher hapten loading.

8MTT-Bromoacetate
8MTT-Bromoacetate-1mg 1 mg Ask for price
Description: 8MTTis the first commercially available, full-length, genetically detoxified tetanus toxin. As a full-length protein, 8MTT contains all the tetanus toxin epitopes. 8MTT is more thermal and pH stable than CRM197. 8MTT is comparable to tetanus toxoid as a carrier protein. At 150 kDa, 8MTT is about 3 times the mass of CRM197and has ~35 surface accessible lysines vs ~10 for the latter, allowing for higher hapten loading.

8MTT-Bromoacetate
8MTT-Bromoacetate-25mg 25 mg Ask for price
Description: 8MTTis the first commercially available, full-length, genetically detoxified tetanus toxin. As a full-length protein, 8MTT contains all the tetanus toxin epitopes. 8MTT is more thermal and pH stable than CRM197. 8MTT is comparable to tetanus toxoid as a carrier protein. At 150 kDa, 8MTT is about 3 times the mass of CRM197and has ~35 surface accessible lysines vs ~10 for the latter, allowing for higher hapten loading.

8MTT-Bromoacetate
8MTT-Bromoacetate-5mg 5 mg Ask for price
Description: 8MTTis the first commercially available, full-length, genetically detoxified tetanus toxin. As a full-length protein, 8MTT contains all the tetanus toxin epitopes. 8MTT is more thermal and pH stable than CRM197. 8MTT is comparable to tetanus toxoid as a carrier protein. At 150 kDa, 8MTT is about 3 times the mass of CRM197and has ~35 surface accessible lysines vs ~10 for the latter, allowing for higher hapten loading.

8MTT-maleimide
8MTT-maleimide-10mg 10 mg Ask for price
Description: 8MTTis the first commercially available, full-length, genetically detoxified tetanus toxin. As a full-length protein, 8MTT contains all the tetanus toxin epitopes. 8MTT is more thermal and pH stable than CRM197. 8MTT is comparable to tetanus toxoid as a carrier protein. At 150 kDa, 8MTT is about 3 times the mass of CRM197and has ~35 surface accessible lysines vs ~10 for the latter, allowing for higher hapten loading.

8MTT-azide
8MTT-maleimide-10mg/03 10 mg Ask for price
Description: 8MTTis the first commercially available, full-length, genetically detoxified tetanus toxin. As a full-length protein, 8MTT contains all the tetanus toxin epitopes. 8MTT is more thermal and pH stable than CRM197. 8MTT is comparable to tetanus toxoid as a carrier protein. At 150 kDa, 8MTT is about 3 times the mass of CRM197and has ~35 surface accessible lysines vs ~10 for the latter, allowing for higher hapten loading.

8MTT-maleimide
8MTT-maleimide-1mg 1 mg Ask for price
Description: 8MTTis the first commercially available, full-length, genetically detoxified tetanus toxin. As a full-length protein, 8MTT contains all the tetanus toxin epitopes. 8MTT is more thermal and pH stable than CRM197. 8MTT is comparable to tetanus toxoid as a carrier protein. At 150 kDa, 8MTT is about 3 times the mass of CRM197and has ~35 surface accessible lysines vs ~10 for the latter, allowing for higher hapten loading.

8MTT-azide
8MTT-maleimide-1mg/01 1 mg Ask for price
Description: 8MTTis the first commercially available, full-length, genetically detoxified tetanus toxin. As a full-length protein, 8MTT contains all the tetanus toxin epitopes. 8MTT is more thermal and pH stable than CRM197. 8MTT is comparable to tetanus toxoid as a carrier protein. At 150 kDa, 8MTT is about 3 times the mass of CRM197and has ~35 surface accessible lysines vs ~10 for the latter, allowing for higher hapten loading.

8MTT-maleimide
8MTT-maleimide-25mg 25 mg Ask for price
Description: 8MTTis the first commercially available, full-length, genetically detoxified tetanus toxin. As a full-length protein, 8MTT contains all the tetanus toxin epitopes. 8MTT is more thermal and pH stable than CRM197. 8MTT is comparable to tetanus toxoid as a carrier protein. At 150 kDa, 8MTT is about 3 times the mass of CRM197and has ~35 surface accessible lysines vs ~10 for the latter, allowing for higher hapten loading.

8MTT-azide
8MTT-maleimide-25mg/04 25 mg Ask for price
Description: 8MTTis the first commercially available, full-length, genetically detoxified tetanus toxin. As a full-length protein, 8MTT contains all the tetanus toxin epitopes. 8MTT is more thermal and pH stable than CRM197. 8MTT is comparable to tetanus toxoid as a carrier protein. At 150 kDa, 8MTT is about 3 times the mass of CRM197and has ~35 surface accessible lysines vs ~10 for the latter, allowing for higher hapten loading.

8MTT-maleimide
8MTT-maleimide-5mg 5 mg Ask for price
Description: 8MTTis the first commercially available, full-length, genetically detoxified tetanus toxin. As a full-length protein, 8MTT contains all the tetanus toxin epitopes. 8MTT is more thermal and pH stable than CRM197. 8MTT is comparable to tetanus toxoid as a carrier protein. At 150 kDa, 8MTT is about 3 times the mass of CRM197and has ~35 surface accessible lysines vs ~10 for the latter, allowing for higher hapten loading.

8MTT-azide
8MTT-maleimide-5mg/02 5 mg Ask for price
Description: 8MTTis the first commercially available, full-length, genetically detoxified tetanus toxin. As a full-length protein, 8MTT contains all the tetanus toxin epitopes. 8MTT is more thermal and pH stable than CRM197. 8MTT is comparable to tetanus toxoid as a carrier protein. At 150 kDa, 8MTT is about 3 times the mass of CRM197and has ~35 surface accessible lysines vs ~10 for the latter, allowing for higher hapten loading.

110 kDa Amino Dextran
AD110x10
  • Ask for price
  • Ask for price
  • 100 mg
  • 500 mg
Description: Amino-Dextran (AmDex, AECM-dextran) consists of dextran functionalized with primary amines. (See “Diagram” Tab for the structure of FinaBio amino dextran.) Our AmDex is prepared from dextran using a protocol yielding a stable, amino functionalized dextran that is superior to the more commonly used reductive amination methods. The molecular weight profile of Fina Biosolutions’ AmDex is essentially unchanged from the starting dextran, as determined by analytical size exclusion chromatography. The product is desalted and lyophilized. We do extensive processing and testing to ensure that free amino reagent is removed, resulting in a consistent product with minimal lot-to-lot variation. We have found that many commercial lots of amino-dextran contain variable amounts of dextran and that the amine content is often incorrect. Furthermore, the actual polymer molecular weight distributions of these preparations can vary extensively from the indicated molecular weight. These issues can mean that optimization data is based on incorrect information. Lot-to-lot variations means that protocols may need to be revised when a new lot of AmDex is used. Please contact us if you need a ratio that is not listed.

110 kDa Amino Dextran
AD110x100
  • Ask for price
  • Ask for price
  • 100 mg
  • 500 mg
Description: Amino-Dextran (AmDex, AECM-dextran) consists of dextran functionalized with primary amines. (See “Diagram” Tab for the structure of FinaBio amino dextran.) Our AmDex is prepared from dextran using a protocol yielding a stable, amino functionalized dextran that is superior to the more commonly used reductive amination methods. The molecular weight profile of Fina Biosolutions’ AmDex is essentially unchanged from the starting dextran, as determined by analytical size exclusion chromatography. The product is desalted and lyophilized. We do extensive processing and testing to ensure that free amino reagent is removed, resulting in a consistent product with minimal lot-to-lot variation. We have found that many commercial lots of amino-dextran contain variable amounts of dextran and that the amine content is often incorrect. Furthermore, the actual polymer molecular weight distributions of these preparations can vary extensively from the indicated molecular weight. These issues can mean that optimization data is based on incorrect information. Lot-to-lot variations means that protocols may need to be revised when a new lot of AmDex is used. Please contact us if you need a ratio that is not listed.

110 kDa Amino Dextran
AD110x25
  • Ask for price
  • Ask for price
  • 100 mg
  • 500 mg
Description: Amino-Dextran (AmDex, AECM-dextran) consists of dextran functionalized with primary amines. (See “Diagram” Tab for the structure of FinaBio amino dextran.) Our AmDex is prepared from dextran using a protocol yielding a stable, amino functionalized dextran that is superior to the more commonly used reductive amination methods. The molecular weight profile of Fina Biosolutions’ AmDex is essentially unchanged from the starting dextran, as determined by analytical size exclusion chromatography. The product is desalted and lyophilized. We do extensive processing and testing to ensure that free amino reagent is removed, resulting in a consistent product with minimal lot-to-lot variation. We have found that many commercial lots of amino-dextran contain variable amounts of dextran and that the amine content is often incorrect. Furthermore, the actual polymer molecular weight distributions of these preparations can vary extensively from the indicated molecular weight. These issues can mean that optimization data is based on incorrect information. Lot-to-lot variations means that protocols may need to be revised when a new lot of AmDex is used. Please contact us if you need a ratio that is not listed.